RxDoctor Payments Data
★ My doctorsLook up a doctor →

Heather Luing, MD

Psychiatry · Saint Augustine, FLNPI 1952477366

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,097,788 of the $1,457,488 with a category attached, or 75.3%. 21 manufacturers reported payments, led by Alkermes, Inc. at 36.6% of the total. 2025 is the largest year on record at $402,732, 3.3 times the $121,906 reported in 2019. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,457,488in general payments, 2019–2025

Across 2,039 payments — averaging $714.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$534K
  • Johnson & Johnson$335K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$225K
  • Axsome Therapeutics, Inc.$183K
  • Teva Pharmaceuticals USA, Inc.$59K
  • E.r. Squibb & Sons, L.L.C.$55K
  • plus $66K from 15 others
$497,535in research payments, 2019–2025

Across 220 payments — averaging $2261.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Livanova USA, Inc.$451K
  • Janssen Research & Development, LLC$47K

What the payments were for

  • Consulting fees$158,68211%
  • Speaking & faculty fees$1,097,78875%
  • Travel & lodging$160,12911%
  • Food & beverage$40,8733%
  • Education$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alkermes, Inc.691$534,147
Johnson & Johnson611$334,877
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)274$225,135
Axsome Therapeutics, Inc.203$183,499
Teva Pharmaceuticals USA, Inc.65$59,014
E.r. Squibb & Sons, L.L.C.59$55,000
Vanda Pharmaceuticals Inc.60$42,350
Neurocrine Biosciences, Inc.27$15,513
Otsuka Pharmaceutical Development & Commercialization, Inc.11$4,525
Biogen2$1,535
Livanova USA, Inc.11$568
AbbVie11$417
Janssen Scientific Affairs, LLC2$400
Otsuka America Pharmaceutical, Inc.5$164
Sunovion Pharmaceuticals Inc.1$125
Bristol Myers Squibb1$74
Avanir Pharmaceuticals, Inc.1$65
Sage Therapeutics, LLC1$29
Bausch Health US, LLC1$21
Collegium Pharmaceutical, Inc.1$18
USWM, LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,457,488 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Medicare billing

Part B allowed, 2024
$157,052
Medicare patients
39
Services billed
1,151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Saint Augustine

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →